To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis

A Multi-center, Prospective, Observational Study to Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis

This study aims to evaluate the improvement effect on subjective symptoms of gastritis and adverse events through patient self-assessment results (PRO) by conducting follow-up observations for patients with gastritis at 2 to 4 weeks after administration of Mucotra® SR tablets.

Inclusion Criteria:

• Men or women aged ≥ 19 years
• Subjects with acute or chronic gastritis, requiring treatment with Mucotra® SR tab
• Subjects with subjective symptoms
• Subjects who voluntarily consent to participate in this observational study

Exclusion Criteria:

• Subjects who have had a hypersensitivity reaction to the components of Mucotra® SR tab
• Subject with genetic disorders such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption